Genomics in Cancer Care, Growth, Opportunity, Global Market Report 2025 to 2034

Genomics In Cancer Care

What Are The Historic And Forecasted Growth Rates For The Genomics In Cancer Care Market?

The genomics in cancer care market size has seen rapid growth in the recent years, growing from $17.6 billion in 2024 to an expected $20.73 billion in 2025 at a Compound Annual Growth Rate (CAGR) of 17.8%. This growth in the historic period can be attributed to factors such as early research and development, development of companion diagnostics, ethical and legal frameworks, data standardization and interpretation, and initial market penetration. Market size is projected to see rapid growth in the next few years, estimated to grow to $38.57 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 16.8%. This growth can be attributed to increasing prevalence of cancer, advancements in data analytics, market expansion in emerging economies, genomic data privacy, security, and improvements in healthcare infrastructure. Major trends for the forecast period include technological advancements, personalized medicine, reduced costs of genomic sequencing, regulatory support and guidelines, and increasing patient awareness and demand.

Get Your Free Sample of The Global Genomics In Cancer Care Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8159&type=smp

What Are The Key Growth Drivers for The Genomics In Cancer Care Market?

The growth of genomics in cancer care market is driven by growing demand for cancer diagnostics. Cancer diagnostics involve identifying the right tumor type, location, extent, and stage by tests and procedures that confirm the disease’s presence. Genomics in cancer care aids in determining a suitable treatment plan for cancer patients by recognizing their genetic backgrounds. For instance, Cancer Research UK projected that the average annual number of new cancer cases in the UK is expected to increase from approximately 420,000 cases during 2023-2025 to about 506,000 cases by 2038-2040. Therefore, this increasing demand for cancer diagnostics is expected to accelerate the genomics in the cancer care market.

What Are The Dominant Segments In The Genomics In Cancer Care Market?

• By Product Type: Instruments, Consumables, Services
• By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies
• By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research
• By End User: Hospitals, Government Institutes, Research Facilities

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Who Are The Key Players in The Genomics In Cancer Care Market?

Major companies operating in the genomics in cancer care market include Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., NeoGenomics Laboratories, Foundation Medicine Inc., and many others.

What New Trends Are Emerging In The Genomics In Cancer Care Market?

Robotic genomic testing facilities are a major emerging trend in the genomics in cancer care market. This new approach enhances the accuracy and efficiency of genetic testing, reduces turnaround times, and improves patient outcomes by enabling personalized treatment strategies based on individual genetic profiles. Companies and health institutions are investing in advanced lab facilities equipped with automated systems and robotic technologies to perform various genomic analyses.

Which Region Was The Largest In The Genomics In Cancer Care Market In 2024?

In 2024, North America was the largest region in the genomics in cancer care market, while Asia-Pacific is projected to be the fastest-growing region in the forecast period. The report includes analyses and data from other regions, including Western Europe, Eastern Europe, South America, Middle East and Africa.

What Does The Genomics In Cancer Care Market Report 2025 Offer?

Genomics in cancer care refers to the examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells to provide better cancer treatment. It detects cancer-causing mutations, enhances tumor-specific diagnostic techniques, enables precision medicine research, drug development, and allows the development of targeted therapies for personalized medical treatment. The Genomics In Cancer Care Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8159

Contact Information:

About The Business Research Company:
We offer a variety of services from over 15000+ reports from 27 industries covering 60+ geographies. We have built a reputation for offering comprehensive, data-rich research and insights. With access to over 1,500,000 datasets, the benefit of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *